NCT02686398View on ClinicalTrials.gov

Immunogenicity of a Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Undergoing Hemodialysis

PHASE4CompletedINTERVENTIONAL
Enrollment

174

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
InfluenzaEnd Stage Renal FailureChronic Kidney Disease
Interventions
BIOLOGICAL

Fluad

BIOLOGICAL

Agrippal

All Listed Sponsors
lead

Korea University Guro Hospital

OTHER

NCT02686398 - Immunogenicity of a Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Undergoing Hemodialysis | Biotech Hunter | Biotech Hunter